# Southside Bancshares Inc: overview

SBSI · NYSE · CIK 705432 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbsi.md) · [Financials](/companies/sbsi/financials.md) · [Filings](/companies/sbsi/filings.md) · [Insiders](/companies/sbsi/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | not reported | [0.71](/filings/0000705432-26-000079.md) | [0.72](/filings/0000705432-26-000105.md) | [0.16](/filings/0000705432-26-000111.md) | not reported | [0.78](/filings/0000705432-26-000079.md) | [0.90](/filings/0000705432-26-000105.md) | [0.93](/filings/0000705432-26-000111.md) |
| Free cash flow | $m | [33.7 d](/filings/0000705432-26-000034.md) | [21.5](/filings/0000705432-26-000079.md) | [(2.0) d](/filings/0000705432-26-000105.md) | [37.4 d](/filings/0000705432-26-000111.md) | [16.6 d](/filings/0000705432-26-000034.md) | [45.0](/filings/0000705432-26-000079.md) | [27.5 d](/filings/0000705432-26-000105.md) | [65.4 d](/filings/0000705432-26-000111.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [3.47](/filings/0000705432-24-000026.md) | [3.26](/filings/0000705432-25-000020.md) | [2.82](/filings/0000705432-26-000034.md) | [2.91](/filings/0000705432-26-000034.md) | [2.29](/filings/0000705432-26-000034.md) |
| Free cash flow | $m | [148](/filings/0000705432-24-000026.md) | [217](/filings/0000705432-25-000020.md) | [73.0](/filings/0000705432-26-000034.md) | [90.7](/filings/0000705432-26-000034.md) | [73.5](/filings/0000705432-26-000034.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sbsi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $150.3m | 4,271,247 |  | Added +69,751 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $49.5m | 1,406,812 |  | Added +22,067 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $46.7m | 1,328,182 |  | Added +34,564 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $43.9m | 1,248,193 |  | Added +11,072 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $26.0m | 737,957 |  | Added +16,543 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $22.2m | 630,384 |  | Added +41,333 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $14.7m | 419,146 |  | Reduced −21,000 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $12.7m | 360,385 |  | Reduced −29,482 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $12.3m | 348,461 |  | Reduced −46,359 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $12.1m | 342,761 |  | Added +23,535 |

## Recent filings

[All 2,083 filings](/companies/sbsi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 15:13 ET | [10-Q](/filings/0000705432-26-000111.md) | Quarterly report, period 2026-09-30 | 0000705432-26-000111 |
| 2026-10-29 | 17:45 ET | [8-K](/filings/0000705432-26-000109.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000705432-26-000109 |
| 2026-07-24 | 14:04 ET | [10-Q](/filings/0000705432-26-000105.md) | Quarterly report, period 2026-06-30 | 0000705432-26-000105 |
| 2026-07-24 | 17:51 ET | [8-K](/filings/0000705432-26-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000705432-26-000103 |
| 2026-05-20 | 16:03 ET | [8-K](/filings/0000705432-26-000093.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000705432-26-000093 |
| 2026-04-30 | 14:51 ET | [10-Q](/filings/0000705432-26-000079.md) | Quarterly report, period 2026-03-31 | 0000705432-26-000079 |
| 2026-04-30 | 17:49 ET | [8-K](/filings/0000705432-26-000076.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000705432-26-000076 |
| 2026-03-25 | 16:13 ET | [DEF 14A](/filings/0000705432-26-000069.md) | Proxy statement, period 2026-05-14 | 0000705432-26-000069 |
| 2026-02-27 | 16:33 ET | [10-K](/filings/0000705432-26-000034.md) | Annual report, period 2025-12-31 | 0000705432-26-000034 |
| 2026-02-20 | 16:10 ET | [8-K](/filings/0000705432-26-000029.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000705432-26-000029 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000705432-26-000034.md), filed Feb 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 705432
- Tickers: SBSI
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: TX
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 15:21 ET. No prices; not investment advice.